MoonLake Immunotherapeutics
MLTX
#6230
Rank
โ‚น102.08 B
Marketcap
โ‚น1,200
Share price
1.29%
Change (1 day)
-75.29%
Change (1 year)

EPS for MoonLake Immunotherapeutics (MLTX)

EPS in 2026 (TTM): -โ‚น317.76

According to MoonLake Immunotherapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น342.18. In 2024 the company made an earnings per share (EPS) of -โ‚น180.65.

EPS history for MoonLake Immunotherapeutics from 2022 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น317.76
2024-โ‚น180.65
2022-โ‚น129.04